digiMedical Solutions, Inc. Signs Contract With Dr. Betsy Brothers to Implement Microsoft-Based Proprietary Technology Solutions
03 June 2008 - 11:06PM
Marketwired
COLLEYVILLE, TX announced today that the Company has signed a
contract with Dr. Betsy Brothers to implement the Company's
Microsoft-based digital prescription handling software, digiRX and
digiReauth, and to supply call center services to support the
reauthorization of prescriptions. Dr. Brothers, an OBGYN, currently
practices at Southwest Florida Women's Group, P.A. in Naples,
Florida.
Dr. Brothers received both her undergraduate degree and medical
degree from LSU Medical School in New Orleans. Upon completing her
residency at Vanderbilt University Medical Center in Nashville, she
practiced medicine in Tennessee until relocating to Naples in
2001.
Earlier this year the Company announced increased sales efforts
in their current Florida markets. The Company's sales expansion
efforts have been realized by adding new doctors to the Company's
network. Each new doctor contract can add hundreds of patients to
the digiRX network, who in turn drive prescription sales into
company-owned pharmacies and increase company revenue. digiMedical
is actively expanding their regional footprint in the Naples area
in support of the 2008 revenue goal of $10 million.
This contract follows multiple recent contracts with doctors in
the area, to include Dr. Angela Marshall of Southwest Florida
Women's Group, P.A., Dr. Moorthy of Pain Management Center of
Naples, Dr. Shardul Nanavati, founder of Advanced Gastroenterology,
Drs. Romero, Tineo and Seibert of Oaktree Family Practice,
Orthopedic Surgeon Dr. Howard Kapp of Anchor Health Centers, Drs.
Santos-Ocampo, Axline and Spilker of the Collier Heart Group, the
Medical Director of Vanish Vein and Laser Center and Dr. Wey of the
Neuroscience and Spine Associates in Naples, Florida among
others.
digiMedical Prescription Handling Software and Pharmacies
digiMedical Solutions, a Microsoft Partner, with operations in
Texas and Florida, has built its own suite of proprietary software
to handle prescriptions digitally from the physician's office to
the pharmacy, securely and in compliance with all DEA and HIPAA
requirements. The suite of software includes digiRX, digiRxStream,
digiReauth, digiRxComp, and now digiAccounting and the Company owns
and operates five pharmacies throughout Texas and Florida.
Company Fact Sheet and Updates
To be added to digiMedical's corporate e-mail list for
shareholders and interested investors or to receive a Fact Sheet on
the company, please send an e-mail to ir@digimedical.com.
About digiMedical Solutions, Inc.(TM)
digiMedical Solutions, Inc.(TM) (www.digimedical.com) is a
pharmacy and medical technology company focused on developing next
generation digital medical technology with an emphasis on digital
prescriptions (d-Prescriptions) that will more closely align the
doctor, pharmacist and patient. The company's planned growth will
come from three channels: direct marketing of the company's
wireless base d-prescription technology to doctors, acquisition of
independent pharmacy chains and the sale of certain territories to
"market partners" licensed to exploit the digiMedical Solutions(TM)
model. digiMedical Solutions, Inc.(TM) currently owns and operates
five (5) pharmacies located in Texas and Florida. digiMedical
Solutions'(TM) unique business model brings doctor, patients and
pharmacies into next generation medical technologies.
Forward-Looking Statement
Statements included in this press release which are not
historical in nature, are intended to be, and are hereby identified
as "Forward-Looking Statements" for purposes of safe harbor
provided by Section 21E of the Securities Exchange Act of 1934, as
amended. Forward-Looking Statements may be identified by words
including "anticipate," "await," "envision," "foresee," "aim at,"
"believe," "intends," "estimates" including without limitation,
those relating to the company's future business prospects, are
subject to certain risks and uncertainties that could cause actual
results to differ materially from those indicated in the
Forward-Looking Statements. Readers are directed to the company's
filings with the U.S. Securities and Exchange Commission for
additional information and a presentation of the risks and
uncertainties that may affect the company's business and results of
operations.
digiMedical Solutions, Inc. Investor Relations
ir@digimedical.com 214-722-3029
DigiMedical Solutions (CE) (USOTC:DGMS)
Historical Stock Chart
From May 2024 to Jun 2024
DigiMedical Solutions (CE) (USOTC:DGMS)
Historical Stock Chart
From Jun 2023 to Jun 2024